Loading…

Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid

A new series of 4-substituted pipecolic acid derivatives was prepared and incorporated into dipeptoids. The resulting products behave as moderately potent CCK-B antagonists but their constrained structure and its comparison with structurally related compounds yield valuable information about the con...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 1998-06, Vol.8 (11), p.1419-1424
Main Authors: BELLIER, B, DA NASCIMENTO, S, MEUDAL, H, GINCEL, E, ROQUES, B. P, GARBAY, C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c367t-2fd7afa1d6f61b1c37a21710dd036c66f63bf4ef4eb6ce573d4555b430785da23
cites cdi_FETCH-LOGICAL-c367t-2fd7afa1d6f61b1c37a21710dd036c66f63bf4ef4eb6ce573d4555b430785da23
container_end_page 1424
container_issue 11
container_start_page 1419
container_title Bioorganic & medicinal chemistry letters
container_volume 8
creator BELLIER, B
DA NASCIMENTO, S
MEUDAL, H
GINCEL, E
ROQUES, B. P
GARBAY, C
description A new series of 4-substituted pipecolic acid derivatives was prepared and incorporated into dipeptoids. The resulting products behave as moderately potent CCK-B antagonists but their constrained structure and its comparison with structurally related compounds yield valuable information about the conformational requirements for optimal recognition of the CCK-B receptor by antagonists.
doi_str_mv 10.1016/S0960-894X(98)00231-5
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02122133v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69117812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-2fd7afa1d6f61b1c37a21710dd036c66f63bf4ef4eb6ce573d4555b430785da23</originalsourceid><addsrcrecordid>eNo9kNtKxDAQhoMo63p4hIVeiOhFNZNje6mLJ1z0QgXvQpqkGuk2Neku-PZ2DywMDMx88w98CE0AXwEGcf2GS4HzomSfF2VxiTGhkPM9NAYmWE4Z5vtovEMO0VFKPxgDw4yN0KgsJEgpx-jpJSxdk5nQpj5q3zqbTafP-W1mfee6Pnib6bbXX6H1qU-ZddEvB6aOYZ51A2JC402mjbcn6KDWTXKn236MPu7v3qeP-ez14Wl6M8sNFbLPSW2lrjVYUQuowFCpCUjA1mIqjBimtKqZG6oSxnFJLeOcV4xiWXCrCT1Gl5vcb92oLvq5jn8qaK8eb2ZqNcMECAFKlzCw5xu2i-F34VKv5j4Z1zS6dWGRlCgBZAGrUL4BTQwpRVfvkgGrlW611q1WLlVZqLVuxYe7yfbBopo7u7va-h32Z9u9TkY3ddSt8WmHESIYQEH_AfhDhww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69117812</pqid></control><display><type>article</type><title>Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid</title><source>ScienceDirect Freedom Collection</source><creator>BELLIER, B ; DA NASCIMENTO, S ; MEUDAL, H ; GINCEL, E ; ROQUES, B. P ; GARBAY, C</creator><creatorcontrib>BELLIER, B ; DA NASCIMENTO, S ; MEUDAL, H ; GINCEL, E ; ROQUES, B. P ; GARBAY, C</creatorcontrib><description>A new series of 4-substituted pipecolic acid derivatives was prepared and incorporated into dipeptoids. The resulting products behave as moderately potent CCK-B antagonists but their constrained structure and its comparison with structurally related compounds yield valuable information about the conformational requirements for optimal recognition of the CCK-B receptor by antagonists.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(98)00231-5</identifier><identifier>PMID: 9871777</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Animals ; Biological and medical sciences ; Cerebral Cortex - metabolism ; CHO Cells ; Cholecystokinin - metabolism ; Cricetinae ; Guinea Pigs ; In Vitro Techniques ; Life Sciences ; Medical sciences ; Models, Molecular ; Molecular Conformation ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pancreas - metabolism ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Pipecolic Acids - chemical synthesis ; Pipecolic Acids - chemistry ; Pipecolic Acids - pharmacology ; Protein Conformation ; Rats ; Receptor, Cholecystokinin B ; Receptors, Cholecystokinin - antagonists &amp; inhibitors ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 1998-06, Vol.8 (11), p.1419-1424</ispartof><rights>1998 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-2fd7afa1d6f61b1c37a21710dd036c66f63bf4ef4eb6ce573d4555b430785da23</citedby><cites>FETCH-LOGICAL-c367t-2fd7afa1d6f61b1c37a21710dd036c66f63bf4ef4eb6ce573d4555b430785da23</cites><orcidid>0000-0002-9198-9162 ; 0000-0002-9642-3643</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2264118$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9871777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02122133$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>BELLIER, B</creatorcontrib><creatorcontrib>DA NASCIMENTO, S</creatorcontrib><creatorcontrib>MEUDAL, H</creatorcontrib><creatorcontrib>GINCEL, E</creatorcontrib><creatorcontrib>ROQUES, B. P</creatorcontrib><creatorcontrib>GARBAY, C</creatorcontrib><title>Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A new series of 4-substituted pipecolic acid derivatives was prepared and incorporated into dipeptoids. The resulting products behave as moderately potent CCK-B antagonists but their constrained structure and its comparison with structurally related compounds yield valuable information about the conformational requirements for optimal recognition of the CCK-B receptor by antagonists.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cerebral Cortex - metabolism</subject><subject>CHO Cells</subject><subject>Cholecystokinin - metabolism</subject><subject>Cricetinae</subject><subject>Guinea Pigs</subject><subject>In Vitro Techniques</subject><subject>Life Sciences</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pancreas - metabolism</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Pipecolic Acids - chemical synthesis</subject><subject>Pipecolic Acids - chemistry</subject><subject>Pipecolic Acids - pharmacology</subject><subject>Protein Conformation</subject><subject>Rats</subject><subject>Receptor, Cholecystokinin B</subject><subject>Receptors, Cholecystokinin - antagonists &amp; inhibitors</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNo9kNtKxDAQhoMo63p4hIVeiOhFNZNje6mLJ1z0QgXvQpqkGuk2Neku-PZ2DywMDMx88w98CE0AXwEGcf2GS4HzomSfF2VxiTGhkPM9NAYmWE4Z5vtovEMO0VFKPxgDw4yN0KgsJEgpx-jpJSxdk5nQpj5q3zqbTafP-W1mfee6Pnib6bbXX6H1qU-ZddEvB6aOYZ51A2JC402mjbcn6KDWTXKn236MPu7v3qeP-ez14Wl6M8sNFbLPSW2lrjVYUQuowFCpCUjA1mIqjBimtKqZG6oSxnFJLeOcV4xiWXCrCT1Gl5vcb92oLvq5jn8qaK8eb2ZqNcMECAFKlzCw5xu2i-F34VKv5j4Z1zS6dWGRlCgBZAGrUL4BTQwpRVfvkgGrlW611q1WLlVZqLVuxYe7yfbBopo7u7va-h32Z9u9TkY3ddSt8WmHESIYQEH_AfhDhww</recordid><startdate>19980602</startdate><enddate>19980602</enddate><creator>BELLIER, B</creator><creator>DA NASCIMENTO, S</creator><creator>MEUDAL, H</creator><creator>GINCEL, E</creator><creator>ROQUES, B. P</creator><creator>GARBAY, C</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-9198-9162</orcidid><orcidid>https://orcid.org/0000-0002-9642-3643</orcidid></search><sort><creationdate>19980602</creationdate><title>Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid</title><author>BELLIER, B ; DA NASCIMENTO, S ; MEUDAL, H ; GINCEL, E ; ROQUES, B. P ; GARBAY, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-2fd7afa1d6f61b1c37a21710dd036c66f63bf4ef4eb6ce573d4555b430785da23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cerebral Cortex - metabolism</topic><topic>CHO Cells</topic><topic>Cholecystokinin - metabolism</topic><topic>Cricetinae</topic><topic>Guinea Pigs</topic><topic>In Vitro Techniques</topic><topic>Life Sciences</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pancreas - metabolism</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Pipecolic Acids - chemical synthesis</topic><topic>Pipecolic Acids - chemistry</topic><topic>Pipecolic Acids - pharmacology</topic><topic>Protein Conformation</topic><topic>Rats</topic><topic>Receptor, Cholecystokinin B</topic><topic>Receptors, Cholecystokinin - antagonists &amp; inhibitors</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BELLIER, B</creatorcontrib><creatorcontrib>DA NASCIMENTO, S</creatorcontrib><creatorcontrib>MEUDAL, H</creatorcontrib><creatorcontrib>GINCEL, E</creatorcontrib><creatorcontrib>ROQUES, B. P</creatorcontrib><creatorcontrib>GARBAY, C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BELLIER, B</au><au>DA NASCIMENTO, S</au><au>MEUDAL, H</au><au>GINCEL, E</au><au>ROQUES, B. P</au><au>GARBAY, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>1998-06-02</date><risdate>1998</risdate><volume>8</volume><issue>11</issue><spage>1419</spage><epage>1424</epage><pages>1419-1424</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A new series of 4-substituted pipecolic acid derivatives was prepared and incorporated into dipeptoids. The resulting products behave as moderately potent CCK-B antagonists but their constrained structure and its comparison with structurally related compounds yield valuable information about the conformational requirements for optimal recognition of the CCK-B receptor by antagonists.</abstract><cop>Oxford</cop><pub>Elsevier</pub><pmid>9871777</pmid><doi>10.1016/S0960-894X(98)00231-5</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-9198-9162</orcidid><orcidid>https://orcid.org/0000-0002-9642-3643</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 1998-06, Vol.8 (11), p.1419-1424
issn 0960-894X
1464-3405
language eng
recordid cdi_hal_primary_oai_HAL_hal_02122133v1
source ScienceDirect Freedom Collection
subjects Animals
Biological and medical sciences
Cerebral Cortex - metabolism
CHO Cells
Cholecystokinin - metabolism
Cricetinae
Guinea Pigs
In Vitro Techniques
Life Sciences
Medical sciences
Models, Molecular
Molecular Conformation
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pancreas - metabolism
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Pipecolic Acids - chemical synthesis
Pipecolic Acids - chemistry
Pipecolic Acids - pharmacology
Protein Conformation
Rats
Receptor, Cholecystokinin B
Receptors, Cholecystokinin - antagonists & inhibitors
Structure-Activity Relationship
title Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20constrained%20CCK-B%20dipeptoid%20antagonists%20derived%20from%20pipecolic%20acid&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=BELLIER,%20B&rft.date=1998-06-02&rft.volume=8&rft.issue=11&rft.spage=1419&rft.epage=1424&rft.pages=1419-1424&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(98)00231-5&rft_dat=%3Cproquest_hal_p%3E69117812%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c367t-2fd7afa1d6f61b1c37a21710dd036c66f63bf4ef4eb6ce573d4555b430785da23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69117812&rft_id=info:pmid/9871777&rfr_iscdi=true